Getting to Zero
Sustainable Financing of National HIV Responses
dos Santos et al. BMC Public Health 2014, 14:80 http://www.biomedcentral.com/1471-2458/14/80
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs programmes: Central African Republic, Democratic Republic ...of Congo, Eswatini, Guinea, Kenya, Malawi, Mozambique, Myanmar and Zimbabwe. With a focus on the financial resources available, this report highlights the current risks and gaps in HIV and TB service delivery in these countries.
Given the findings of gaps in diagnosis, prevention and care services and dwindling resources, MSF calls for a robust assessment of the needs and the resource capacity of each affected country, and calls on international donors to ensure that the financial burden is shared, rather than shifted onto those countries worst affected by the diseases.
more
July 2019
Policy brief
HIV Treatment
PLOS ONE | www.plosone.org 1
January 2014 | Volume 9 | Issue 1 | e86616
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Ce document donne des renseignements permettant d’aider les pays à mettre sur pied des plans de dépistage à la sortie et des modes opératoires normalisés (MON). Cela comprend les méthodes de dépistage, les outils nécessaires et la marche à suivre, la définition des besoins en matière d...e ressources, les messages à diffuser, ainsi que les considérations juridiques concernant le dépistage.
Elles sont destinées à être utilisées dans les pays présentant une transmission du virus Ebola. Elles peuvent également être utilisées comme outil de référence et de planification par tous les pays.
more
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.